Results 51 to 60 of about 12,460 (245)

Free combination of dutasteride plus tamsulosin for the treatment of benign prostatic hyperplasia in South Korea: analysis of drug utilization and adverse events using the National Health Insurance Review and Assessment Service database

open access: yesBMC Urology, 2021
Objective To assess the use and safety of free combination therapy (dutasteride and tamsulosin), dutasteride monotherapy, or tamsulosin monotherapy in patients with benign prostatic hyperplasia (BPH).
Zrinka Lulic   +9 more
doaj   +1 more source

Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome [PDF]

open access: yes, 2011
PURPOSE: To evaluate the effect of α1-adrenergic receptor antagonists (α1-ARAs) on pupil diameter and determine whether the diameter predicts intraoperative floppy-iris syndrome (IFIS).
CASUCCIO, Alessandra   +4 more
core   +1 more source

Inability to Perform Retrograde Ureteroscopic Stone Treatment: A Postoperative Anatomical Change After Fleur-de-Lis Abdominoplasty. [PDF]

open access: yesCase Rep Urol
Abdominoplasty is a frequently performed elective procedure, often indicated for patients after substantial weight loss resulting in significant redundant skin. Closing techniques and the lifting of the mons pubis during abdominoplasty have been proposed to alleviate symptoms of stress urinary incontinence by elevating and supporting the urethra ...
Heger PL   +5 more
europepmc   +2 more sources

Tamsulosin and Dementia in old age: Is there any relationship? [PDF]

open access: yesJournal of Neuroscience and Neurological Disorders, 2019
Tamsulosin is used to treat Benign Prostatic Hyperplasia (BPH), prescribed annually to about 12.6 million patients worldwide. It is an alpha-adrenergic antagonist that reduces the tone of the prostate smooth muscle involved in the pathophysiology of BPH.
Rebecca Renata Lapenda do Monte   +4 more
openaire   +7 more sources

Benign prostatic hyperplasia : Part 2-management [PDF]

open access: yes, 2008
Peer reviewedPublisher ...
N'Dow, James, Wilt, Timothy J
core   +2 more sources

Summary of the clinical practice guideline for the management of urinary stones, third edition

open access: yesInternational Journal of Urology, Volume 32, Issue 5, Page 462-474, May 2025.
Abstract This third edition of the Japanese Clinical Practice Guidelines for Urinary stones (2023) has been developed under the leadership of the Japanese Urological Association, the Japanese Society of Endourology and Robotics, and the Japanese Society on Urolithiasis Research. This revision adheres to the Minds Manual for Guideline Development (2017)
Katsuhito Miyazawa   +22 more
wiley   +1 more source

ROLE OF COMBINED KETOCONAZOLE AND TAMSULOSIN IN SUCCESSFUL TRIAL OF VOIDING WITHOUT CATHETER (TWOC) IN PATIENTS WITH ACUTE URINARY RETENTION DUE TO BENIGN PROSTATIC OBSTRUCTION

open access: yesPakistan Armed Forces Medical Journal, 2020
Objective: To compare the frequency of patients with successful Trial of voiding without catheter (TWOC) after acute urinary retention secondary to benign prostatic hyperplasia in patients taking ketoconazole and tamsulosin vs tamsulosin alone.
Muhammad Asim   +7 more
doaj   +3 more sources

Water Vapor Energy Therapy Safely Reduces Urinary Medication Use: A Multicenter Retrospective Real‐World Study in Japan (SCCOP Study 24‐01)

open access: yesInternational Journal of Urology, EarlyView.
ABSTRACT Objective The Japanese guidelines for male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) recommend the water vapor energy therapy (WAVE) procedure only for patients in whom conventional BPH surgery is unsuitable due to advanced age or comorbidities.
Junya Abe   +16 more
wiley   +1 more source

α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways

open access: yesBMC Cardiovascular Disorders, 2023
Background Myocardial infarction (MI) is considered a public health problem. According to the World Health Organization, MI is a leading cause of death and comorbidities worldwide. Activation of the α1A adrenergic receptor is a contributing factor to the
Nawal M. Alrasheed   +7 more
doaj   +1 more source

The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. [PDF]

open access: yes, 2014
OBJECTIVE To evaluate the efficacy and safety of duloxetine hydrochloride in the treatment of patients affected by chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Di Stasi, SM   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy